FDA NDC Directory · JSON-LD · Markdown

Risedronate Sodium

NDC 65862-870 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA206768
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsRISEDRONATE SODIUM (150 mg/1)
Marketing started20161021
Package count2

External sources

Source: openFDA. Public-domain (CC0).